TH42835A - Pharmaceutical constituents with Lamivudine - Google Patents
Pharmaceutical constituents with LamivudineInfo
- Publication number
- TH42835A TH42835A TH9801000955A TH9801000955A TH42835A TH 42835 A TH42835 A TH 42835A TH 9801000955 A TH9801000955 A TH 9801000955A TH 9801000955 A TH9801000955 A TH 9801000955A TH 42835 A TH42835 A TH 42835A
- Authority
- TH
- Thailand
- Prior art keywords
- pharmaceutical
- lamivudine
- mixtures
- mixture
- derivatives
- Prior art date
Links
Abstract
DC60 (29/11/55) การประดิษฐ์นี้เกี่ยวข้องกับสูตรผสมทางเภสัชกรรมชนิดใหม่ที่ประกอบด้วย (2R,ซิส) -4- อะมิโน-1-(2-ไฮดรอกซีเมธิล-1,3-ออกแซไธโอแลน-5-อิล)-(1H)ไพริมิดิน-2-โอน-((-)-2',3'-ไดดีออกซี, 3'-ไธเอซิทิดีน, Epivir Registered Trademark , แลมิวูดีน) และการใช้ในการบำบัดทางการแพทย์ การประดิษฐ์นี้เกี่ยวข้องกับสูตรผสมทางเภสัชกรรมชนิดใหม่ที่ประกอบด้วย (2R,ซิส) -4- อะมิโน-1-(2-ไฮดรอกซีเมธิล-1,3-ออกแซไธโอแลน-5-อิล)-(1H)ไพริมิดิน-2-โอน-((-)-2'',3''-ไดดีออกซี, 3''-ไธเอซิลิดี,Epivir สูตร เคมี ,แลมิวูดีน) และการใช้ในการบำบัดทางการแพทย์ สิทธิบัตรยา DC60 (29/11/55) This invention involves a new pharmaceutical formulation containing (2R, cis) -4-amino-1- (2-hydroxy-methyl-1,3 - oxthyolan-5-il) - (1H) pyrimidin-2-transfer - ((-) - 2 ', 3'-dydoxy, 3'-thiacidine , Epivir Registered Trademark, Lamivudine) and their use in medical therapy. The invention involves a new pharmaceutical formula containing (2R, cis) -4-amino-1- (2-hydroxy-methyl-1,3-oxathiol-5. - il) - (1H) pyrimidin-2-transfer - ((-) - 2 '', 3 '' - dydoxy, 3 '' -thyacilidine, Epivir, chemical formula, and Mivudine) and its use in medical therapy, drug patent
Claims (5)
Publications (2)
Publication Number | Publication Date |
---|---|
TH42835A true TH42835A (en) | 2001-02-05 |
TH49783B TH49783B (en) | 2016-06-09 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2470016C2 (en) | Bipirazole derivative | |
RU2356547C2 (en) | Cancer therapy with using hdac inhibitors | |
EP0221176B1 (en) | Pharmaceutical vehicles for recucing transdermal flux | |
CN1191826C (en) | Pharmaceutical formulation | |
EA200400777A1 (en) | PHARMACEUTICAL COMPOSITIONS PLATINUM CONNECTIONS | |
WO2004000359A1 (en) | Topical pharmaceutical composition comprising skin penetration enhancers for the treatment of warts | |
CZ210496A3 (en) | Method improving solution process of difficult-to dissolve pharmaceutically active compounds | |
HU196706B (en) | Process for producing aqueous dispersion suitable for preparing plaster | |
JPS611623A (en) | Permeation promoting composition and method through skin andmembrane by local drug and general drug | |
DE60126433D1 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS | |
JPS6245535A (en) | Acylcarnitines as absorption enhancer for supplying drug through mucosa of nose, mouth, tongue and vagina | |
JP6908448B2 (en) | Pharmaceutical composition | |
US5624682A (en) | Pharmaceutical formulations based on a ketoprofen solution in soft capsules, and processes for their preparation | |
CN1132475A (en) | Composion for releasing essence for nose | |
WO2000041692A2 (en) | Compositions having improved stability | |
CA2514124A1 (en) | Absorption enhancing agents | |
TH42835A (en) | Pharmaceutical constituents with Lamivudine | |
TH49783B (en) | Pharmaceutical constituents with Lamivudine | |
JPS5781409A (en) | External plaster | |
KR860000841B1 (en) | Process of preparing stable concentrated solutions of cisplatin | |
WO1988003799A1 (en) | Pharmaceutical vehicles for reducing transdermal flux | |
ATE269352T1 (en) | 4-BENZYLAMINOCINOLINE CONJUGATES WITH BALE ACID AND THEIR HETEROANALOGUES, METHOD FOR THEIR PRODUCTION, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND THEIR USE | |
JPH11199482A (en) | Preparation composition for external use | |
AU609429B2 (en) | Penetration enhancers for transdermal delivery of systemic agents | |
JPH044300B2 (en) |